Placulumab
Placulumab (ART621) is an anti-TNF α monoclonal antibody. Placulumab has anti-inflammatory activity and has potential applications in inflammatory diseases such as arthritis[1].
Product Specifications
CAS Number
[945781-29-3]
Product Name Alternative
ART621; CEP-37247; PN0621
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/placulumab.html
Purity
97.09
Solubility
10 mM in DMSO
Smiles
[Placulumab]
Molecular Weight
(76.12 kDa)
References & Citations
[1]Gay RD, et al. Anti-TNFα domain antibody construct CEP-37247: Full antibody functionality at half the size. MAbs. 2010 Nov-Dec;2 (6) :625-38.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C2272-71H-APC 100 µL
CD21 (CD21 Antigen, Complement Component (3d/Epstein Barr Virus) Receptor 2, Complement Receptor 2, Complement Receptor Type 2 Precursor, CR2, Complement C3d Receptor, C3DR, Epstein-Barr Virus Receptor, EBV Receptor, SLEB9) (APC)
Ask
View Details 
MBS1225562-01 0.05 mg (E-Coli)
Recombinant Buchnera aphidicola subsp. Acyrthosiphon pisum Lipoprotein-releasing system ATP-binding protein LolD (lolD)
Ask
View Details MBS1225562-02 0.05 mg (Yeast)
Recombinant Buchnera aphidicola subsp. Acyrthosiphon pisum Lipoprotein-releasing system ATP-binding protein LolD (lolD)
Ask
View Details MBS1225562-03 0.2 mg (E-Coli)
Recombinant Buchnera aphidicola subsp. Acyrthosiphon pisum Lipoprotein-releasing system ATP-binding protein LolD (lolD)
Ask
View Details